Table 3.

Association between EF+LVEDD and mortality using parametric models for interval-censored survival-time data based on complete data (n = 797).

	Model 1	p-Value	Model 2	p-Value	Model 3	p-Value
All-cause mortality
Q1 (<103)	1.89 (1.23–2.89)	0.003	1.49 (0.97–2.30)	0.068	1.49 (0.96–2.31)	0.075
Q2 (103–107)	Reference	–	Reference	–	Reference	–
Q3 (108–114)	1.41 (0.93–2.14)	0.108	1.25 (0.82–1.90)	0.305	1.24 (0.81–1.90)	0.317
Q4 (≥115)	2.13 (1.43–3.16)	<0.001	1.88 (1.26–2.80)	0.002	1.70 (1.12–2.56)	0.012
Cardiovascular mortality
Q1 (<103)	2.87 (1.18–6.97)	0.020	2.21 (0.90–5.42)	0.084	2.27 (0.92–5.64)	0.076
Q2 (103–107)	Reference	–	Reference	–	Reference	–
Q3 (108–114)	2.77 (1.18–6.52)	0.020	2.36 (1.00–5.57)	0.050	2.42 (1.02–5.74)	0.046
Q4 (≥115)	3.44 (1.49–7.97)	0.004	2.78 (1.19–6.48)	0.018	2.38 (1.00–5.66)	0.049
Cardiovascular event
Q1 (<103)	1.66 (0.89–3.07)	0.109	1.52 (0.82–2.83)	0.186	1.62 (0.86–3.02)	0.133
Q2 (103–107)	Reference	–	Reference	–	Reference	–
Q3 (108–114)	1.20 (0.65–2.21)	0.560	1.04 (0.56–1.93)	0.898	0.99 (0.53–1.84)	0.981
Q4 (≥115)	1.61 (0.90–2.86)	0.108	1.34 (0.74–2.41)	0.334	1.30 (0.71–2.38)	0.387

Model 1: unadjusted crude HR. Model 2: adjusted for age, sex, BMI, DM, and hypertension. Model 3: model 2 plus albumin, eGFR, cholesterol, calcium, potassium, sodium and centers. Q, quartile; BMI, body mass index; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; HR, hazards ratio; CI, confidence interval.